Home » Topics » Regulatory

Regulatory
RSS

FDA grants accelerated approval to Keytruda and priority review for further indication

May 24, 2017

FDA approves Actemra as first therapy to treat giant cell arteritis

May 23, 2017

FDA approves Keytruda for certain patients with locally advanced or metastatic urothelial carcinoma

May 19, 2017

European Commission approves dinutuximab beta for the treatment of high-risk neuroblastoma

May 11, 2017

FDA approves Bavencio for advanced urothelial carcinoma

May 10, 2017

FDA approves Kisqali Femara Co-Pack

May 10, 2017

FDA approves Tymlos for postmenopausal women with osteoporosis at high risk for fracture

May 3, 2017

FDA grants accelerated approval to Alunbrig for ALK-positive NSCLC

May 2, 2017

FDA approves Rydapt for patients with newly diagnosed AML with FLT3 mutation

May 2, 2017

FDA grants accelerated approval to Imfinzi for previously treated bladder cancer

May 2, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...